Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Brandon W. Higgs, Zheng Liu, Barbara White, Wei Zhu, Wendy I. White, Chris Morehouse, Philip Brohawn, Peter A. Kiener, Laura Richman, David Fiorentino, Steven A. Greenberg, Bahija Jallal, Yihong Yao

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds